跳至主要内容
临床试验/NCT05301569
NCT05301569招募中不适用

Relation Between Serum Insulin Like Growth Factor 1 and Body Mass Index in Acne Vulgaris

Assiut University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2023年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
90
试验地点
1
主要终点
Evaluation of serum level of insulin like growth factor 1 in acne vulgaris

研究概览

简要总结

cross-sectional study in which participants will be recruited at dermatology & Andrology out-patient clinics in Assuit university hospital, Egypt after patients examination by dermatologists & obtaining an informed consent

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
15 Years 至 45 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged from 15 to 45 years old suffering from acne vulgaris.
  • Both sexes.

排除标准

  • Insulin resistance and diabetic patients
  • Females with polycystic ovarian syndrome
  • Treatment with drugs that can influence IGF-1level such as corticosteroid, insulin, hypoglycemic agents, and isotretinoin within one year before the date of study.
  • Other causes of acne or acneform eruption as steroid-induced

结局指标

主要结局

Evaluation of serum level of insulin like growth factor 1 in acne vulgaris

时间窗: 1 year

using the Chemiluminescent Microparticle Immunoassay

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rania Sallam Mohamed Taha

Principal investigator

Assiut University

研究点 (1)

Loading locations...

相似试验